| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |